To Compare efficacy of carboxymethyl cellulose .5% eye drops versus use of 0.5% carboxymethylcellulose eye drop with combination of 0.1% tacrolimus ointment twice daily for treatment of severe dry eyes
Keywords:
Carboxymethylcellulose, Tacrolimus, Dry eyeAbstract
Background: Dry eye disease is a common disorder provoking changes in tear film and ocular surface. Untreated dry eye could cause ocular infections, corneal ulcer and blindness. Only a few drugs are authorized so far for the treatment of severe dry eye disease and the possibilities of evolution in this sector are immense.Objectives: Compare efficacy of carboxy methyl cellulose .5% eye drops versus use of 0.5% carboxy methylcellulose eye drop with combination of 0.1% tacrolimus ointment twice daily for treatment of severe dry eyes.Material and Methods: 40 patient presenting with severe dry eye were selected randomly. They were divided into 2 groups. Group I received CMC.5% eye drops four times a day and group II received of 0.1%tacrolimus ointment two times daily and .5% CMC eye drops 4times a day. All patients were evaluated on day 0, 2 weeks, 1 month, 3 month and 6 month for relief in ocular symptoms and diagnostic dry eye tests.Results:The mean age in group I was 40.72 ± 6.85 years and in group II was 39.2 ± 5.28 years. Ocular discomfort, dryness and tearing were seen in all the cases. Comparison of different parameters after six months of treatment between group I and II showed that the comparision of net score in two groups is statistically significant(p < 0.05). Conclusion: There was statistically significant difference between the outcome of two groups.Group 2 patients who used combination of of 0.1%tacrolimus ointment two times daily along with CMC 0.5% eye drops 4 times a day were better relieved as compared to patients in group 1 who used 0.5% CMC eye drops four times daily for treatment of severe dry eyes
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Prerana Agarwal, SD Tayal, Ankur Gautum
This work is licensed under a Creative Commons Attribution 4.0 International License.